"Uses AI to: Simulate and generate digital control subjects that are statistically indistinguishable from actual controls. Allows researchers to: Populate control arms in clinical trials, enabling rigorous clinical evidence with fewer subjects. Founded: 2017. Headquarters: San Francisco, California, United States."
